(Q44363076)

English

Prognostic value of changes in CD4 count and HIV RNA during the first six months on highly active antiretroviral therapy in chronic human immunodeficiency virus infection

scientific article published in January 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Prognostic value of changes in CD4 count and HIV RNA during the first six months on highly active antiretroviral therapy in chronic human immunodeficiency virus infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

author name string

Vidar Ormaasen

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Johan N Bruun

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Leiv Sandvik

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Mona Holberg-Petersen

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Per Ivar Gaarder

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

6-7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

383-388

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

AIDS across Europe, 1994-98: the EuroSIDA study

1 reference

https://api.crossref.org/works/10.1080%2F00365540310009716

21 January 2018

The relationship between virus load response to highly active antiretroviral therapy and change in CD4 cell counts: A report from the Women's interagency HIV study

1 reference

https://api.crossref.org/works/10.1080%2F00365540310009716

21 January 2018

Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen

1 reference

https://api.crossref.org/works/10.1080%2F00365540310009716

21 January 2018

Patterns of plasma human immunodeficiency virus type 1 RNA response to antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1080%2F00365540310009716

21 January 2018

Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacy

1 reference

https://api.crossref.org/works/10.1080%2F00365540310009716

21 January 2018

Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320.

1 reference

https://api.crossref.org/works/10.1080%2F00365540310009716

21 January 2018

Initial virological and immunologic response to highly active antiretroviral therapy predicts long-term clinical outcome.

1 reference

https://api.crossref.org/works/10.1080%2F00365540310009716

21 January 2018

The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team

1 reference

https://api.crossref.org/works/10.1080%2F00365540310009716

21 January 2018

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1080%2F00365540310009716

21 January 2018

Full suppression of viral load is needed to achieve an optimal CD4 cell count response among patients on triple drug antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1080%2F00365540310009716

21 January 2018

The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1080%2F00365540310009716

21 January 2018

Predictors of optimal virological response to potent antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1080%2F00365540310009716

21 January 2018

Identifiers

10.1080/00365540310009716

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44363076&oldid=2020084376"